Adagene (ADAG) Stock: Buy, Sell, or Hold?
ADAG - Adagene Inc. American Depositary Shares
$2.41
0.06 (2.55%)
â˛
5d:
-9.74%
30d:
-17.75%
90d:
-41.79%
WAIT
LOW Confidence
Analysis Updated: Nov 4, 2026 12:00 AM ET
Earnings: Apr 01, 2026
0d
Get Alerted When ADAG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ADAG is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ADAG is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ADAG is currently trading at $2.41, which is considered slightly low relative to its 30-day fair value range of $2.33 to $2.92.
Technical Outlook: Technically, ADAG is in a strong downtrend. Immediate support is located at $2.17, while resistance sits at $2.78.
Market Sentiment: ADAG scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.91 (+311.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADAG is in a strong downtrend. Immediate support is located at $2.17, while resistance sits at $2.78.
Market Sentiment: ADAG scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $9.91 (+311.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.33 -
$2.92
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 311.1% below Wall St target ($9.91)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.33 -
$2.92
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.17
Resistance Level
$2.78
Current Trend
Strong Downtrend
Technical data as of
Nov 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.10
Wall Street Target
$9.91
(+311.1%)
Revenue Growth (YoY)
7332.8%
Profit Margin
-220.8%
Share & Embed Analysis
Last updated: November 05, 2026 1:38 AM ET
Data refreshes hourly during market hours. Next update: 2:38 AM
Data refreshes hourly during market hours. Next update: 2:38 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADAG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
23 analysts |
$107 | 56 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 42 HOLD |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$685 | 42 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 69 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
23 analysts |
$86 | 57 HOLD |
